Jared Gollob, Chief Medical Officer of Kymera Therapeutics Inc (NASDAQ:KYMR), sold 46,137 shares of the company on February 9, 2024, according to a recent SEC Filing.
On January 23, 2024, Jeffrey Albers, a director at Kymera Therapeutics Inc (NASDAQ:KYMR), executed a sale of 10,000 shares of the company's stock, as reported in a recent SEC Filing.